Lopid Tablet, Film Coated
Product Images NDC 0071-0737

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lopid (NDC 0071-0737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lopid 01)

FDA Label Image

Logo (Lopid 02)

Logo (Lopid 02)
This text indicates that a certain item or product is being distributed by a company called Parke-Davis, which is a division of the larger corporation Pfizer Inc, based in New York City with a ZIP code of 10017.*
FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Principal Display Panel (600 mg Tablet Bottle Label)
Lopid® is a medication available in tablet form and is sold in packs containing 500 tablets. Each tablet contains 600mg of Gemfibrozil and is intended for use for patients who require treatment for elevated cholesterol levels. The medication should be stored in a controlled room that maintains a temperature between 88°F and 77°F, and should be protected from light and humidity. The package contains further information and should be read before use. The National Drug Code (NDC) assigned to this medication is 0071-0737-30.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.